Long-term physiotherapy in patients after stroke, with multiple sclerosis, or with Parkinson’s disease
Some patients after stroke, with multiple sclerosis (MS), or with Parkinson’s disease currently receive physiotherapy over a lengthy period of time (more than 36 physiotherapy sessions per year). The question arises as to whether long-term physiotherapy for these patients has additional benefits compared with those receiving short-term physiotherapy. The aim of the HTA is to assess the efficacy, safety, cost-effectiveness and budgetary impact of long-term physiotherapy for patients after stroke, with MS or Parkinson’s disease. The scoping report showed that no data are currently available for this patient group to conduct an HTA on the efficacy, safety and cost-effectiveness of long-term physiotherapy compared to short-term physiotherapy.